CDK1 protein offers clues to which breast cancers will resist targeted therapy
Researchers at the Garvan Institute of Medical Research have discovered that the activity of a protein called CDK1 in breast cancers is linked to how they respond to a common therapy—an insight that could inform more personalized ...
Oct 30, 2026
0
32









